EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Regulation of CD8 T‐cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid

Raul M Torres iD, Jacqueline A Turner, Marc D'Antonio, Roberta Pelanda iD, Kimberly N Kremer

Immunological Reviews · 2023

DOI: 10.1111/imr.13208 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2023. Verfasst von Raul M Torres und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAAA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysophosphatidic acid (LPA) is an endogenous bioactive lipid that is produced extracellularly and signals to cells via cognate LPA receptors, which are G‐protein coupled receptors (GPCRs). Mature lymphocytes in mice and humans express three LPA receptors, LPA 2 , LPA 5, and LPA 6 , and work from our group has determined that LPA 5 signaling by T lymphocytes inhibits specific antigen‐receptor signaling pathways that ultimately impair lymphocyte activation, proliferation, and function. In this review, we discuss previous and ongoing work characterizing the ability of an LPA‐LPA 5 axis to serve as a peripheral immunological tolerance mechanism that restrains adaptive immunity but is subverted during settings of chronic inflammation. Specifically, LPA‐LPA 5 signaling is found to regulate effector cytotoxic CD8 T cells by (at least) two mechanisms: (i) regulating the actin‐microtubule cytoskeleton in a manner that impairs immunological synapse formation between an effector CD8 T cell and antigen‐specific target cell, thus directly impairing cytotoxic activity, and (ii) shifting T‐cell metabolism to depend on fatty‐acid oxidation for mitochondrial respiration and reducing metabolic efficiency. The in vivo outcome of LPA 5 inhibitory activity impairs CD8 T‐cell killing and tumor immunity in mouse models providing impetus to consider LPA 5 antagonism for the treatment of malignancies and chronic infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesAntineoplastic AgentsHumansMiceAnimalsLysophospholipidsSignal TransductionReceptors, Lysophosphatidic Acid

Stichwörter der Autor:innen

T cellscytotoxiccytotoxicitylipid mediatorssignal transduction cancer

Substanzen

lysophosphatidic acidAntineoplastic AgentsLysophospholipidsReceptors, Lysophosphatidic Acid

Autor:innen und Institutionen

  • Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: Raul M Torres, Roberta Pelanda

Förderung

  • NIAID NIH HHS
  • NIAAA NIH HHS
  • National Institutes of Health

Zitieren

APA

Torres, R. M., Turner, J. A., D'Antonio, M., Pelanda, R., & Kremer, K. N. (2023). Regulation of CD8 T‐cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid. Immunological Reviews. https://doi.org/10.1111/imr.13208

Vancouver

Torres RM, Turner JA, D'Antonio M, Pelanda R, Kremer KN. Regulation of CD8 T‐cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid. Immunological Reviews. 2023. doi:10.1111/imr.13208

BibTeX
@article{Torres2023,
  author = {Torres, Raul M and Turner, Jacqueline A and D'Antonio, Marc and Pelanda, Roberta and Kremer, Kimberly N},
  title = {Regulation of CD8 T‐cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid},
  journal = {Immunological Reviews},
  year = {2023},
  doi = {10.1111/imr.13208}
}
Kostenlos starten →